文献速递免疫规划传染病防控与疫情报告

疫苗驱动肺炎链球菌血清型重排:匈牙利同一时期携带株与临床分离株比较

Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.
PubMed 文献 · Vaccine · 2018-11-22

研究比较2015年3月至2016年5月匈牙利7岁以下健康儿童携带株与同期临床分离株的血清型、耐药性及克隆性。携带率为39.1%,携带株中PCV13血清型仅5.8%,而P1组和P2组分别为17.5%和32.6%。PCV13显著减少疫苗血清型,但血清型重排也见于临床分离株且时间稍晚。

要点

  • 健康儿童携带率为39.1%,携带株中PCV13血清型仅占5.8%。
  • P1组PCV13血清型占17.5%,P2组占32.6%,均高于携带组。
  • 19F在携带株和黏膜感染中重现频率增加,需持续监测。

核心结论

  • PCV13在减少疫苗血清型流行方面高度成功,但血清型重排也见于临床分离株且时间稍晚。

研究设计与样本

  • 2015年3月至2016年5月采集522名7岁以下健康儿童鼻拭子筛查携带,同期收集146株临床分离株(主要来自黏膜感染),比较血清型、耐药性和克隆性。

主要发现

  • 携带率为39.1%,携带株中血清型3和6A完全消失,PCV13血清型仅5.8%(19F、19A、9V),19A显著下降。
  • P1组PCV13血清型占17.5%,血清型3占7.9%,优势血清型为23B(22.2%)。
  • P2组PCV13血清型占32.6%,血清型3占15.7%,血清型分布最多样。
  • 患者分离株对测试抗生素的耐药性高于携带株。

临床怎么用

  • 持续监测携带株和临床分离株的血清型变化,警惕19F等耐药克隆重现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Young children - the main asymptomatic carriers of pneumococcus - are often the source of pneumococcal infections. PCV13 replaced PCV7 in 2010 in Hungary and it became a mandatory vaccine in 2014. In this work we surveyed the effect of vaccination in three groups: in healthy children under 7 years; in children of the same age but infected with pneumococcus (P1); in older patients (P2) who were very likely not vaccinated. Nasal swabs were taken from 522 healthy children to screen pneumococcal carriage between March 2015 and May 2016. In the same time period, 146 clinical isolates were collected, mainly from mucosal infections. Serotypes, antibiotic susceptibility and clonality of the isolates was determined and compared. The carriage rate was 39.1%. Regarding carriage, the serotype distribution showed the total disappearance of serotypes 3 and 6A compared to former Hungarian studies. The prevalence of PCV13 serotypes was only 5.8% represented by three serotypes (19F, 19A, 9V). Of note, serotype 19A (a very resistant and invasive type) also decreased significantly. In the patient groups, PCV13 prevalence was higher: 17.5% (P1) and 32.6% (P2). Although serotype 3 was present in P1 (7.9%), the leading serotype was 23B (22.2%), a non-vaccine type (NVT). P2 showed the most diverse serotype distribution, but serotype 3 was predominant here (15.7%). Pneumococcal isolates from the patients were more resistant towards the tested antibiotics compared to those from carriers. PCV13 seems to be highly successful in reducing the prevalence of vaccine serotypes. The serotype-rearrangement can be seen also among clinical isolates, albeit somewhat later in time. Fortunately, the replacing serotypes are less invasive and less resistant, but, most worrisome, serotype 19F can be found again with increased frequency among carriage isolates and mucosal infections. Further surveillance is needed to carefully monitor such successful, antibiotic resistant "refugees".

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kovács E, Sahin-Tóth J, Tóthpál A, et al. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary. Vaccine. 2018. PMID: 30470639. doi:10.1016/j.vaccine.2018.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。